間欠性跛行(Intermittent Claudication):治療薬のグローバル治験動向(2014年下半期)

◆英語タイトル:Intermittent Claudication Global Clinical Trials Review, H2, 2014
◆商品コード:GDHC2339CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2014年9月21日
◆ページ数:71
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥560,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥840,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Intermittent Claudication Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “Intermittent Claudication Global Clinical Trials Review, H2, 2014″ provides data on the Intermittent Claudication clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Intermittent Claudication. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Intermittent Claudication. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables4
List of Figures 5
Introduction 6
Intermittent Claudication 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Intermittent Claudication to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Intermittent Claudication to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Intermittent Claudication 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Intermittent Claudication Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Sanofi 32
Clinical Trial Overview of Sanofi 32
Cytokinetics, Inc. 33
Clinical Trial Overview of Cytokinetics, Inc. 33
Nissan Chemical Industries, Ltd. 34
Clinical Trial Overview of Nissan Chemical Industries, Ltd. 34
Kowa Company, Ltd. 35
Clinical Trial Overview of Kowa Company, Ltd. 35
ZonMw 36
Clinical Trial Overview of ZonMw 36
Boehringer Ingelheim Auslandsbeteiligungs GmbH 37
Clinical Trial Overview of Boehringer Ingelheim Auslandsbeteiligungs GmbH 37
AstraZeneca PLC 38
Clinical Trial Overview of AstraZeneca PLC 38
Adamed Sp. z o.o. 39
Clinical Trial Overview of Adamed Sp. z o.o. 39
AbbVie Inc. 40
Clinical Trial Overview of AbbVie Inc. 40
Angiogenix, Inc. 41
Clinical Trial Overview of Angiogenix, Inc. 41
Clinical Trial Overview of Top Institutes / Government 42
National Institute on Aging 42
Clinical Trial Overview of National Institute on Aging 42
University Hospital, Angers 43
Clinical Trial Overview of University Hospital, Angers 43
University of Hull 44
Clinical Trial Overview of University of Hull 44
University of Sao Paulo 45
Clinical Trial Overview of University of Sao Paulo 45
Copenhagen University Hospital at Herlev 46
Clinical Trial Overview of Copenhagen University Hospital at Herlev 46
National Heart, Lung, and Blood Institute 47
Clinical Trial Overview of National Heart, Lung, and Blood Institute 47
University of Rochester 48
Clinical Trial Overview of University of Rochester 48
Samsung Medical Center 49
Clinical Trial Overview of Samsung Medical Center 49
Yonsei University 50
Clinical Trial Overview of Yonsei University 50
Sheffield Teaching Hospitals NHS Foundation Trust 51
Clinical Trial Overview of Sheffield Teaching Hospitals NHS Foundation Trust 51
Five Key Clinical Profiles 52
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 71

List of Tables
Intermittent Claudication Therapeutics, Global, Clinical Trials by Region, 2014* 7
Intermittent Claudication Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Intermittent Claudication Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Intermittent Claudication Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Intermittent Claudication Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Intermittent Claudication Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Intermittent Claudication Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Intermittent Claudication Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Intermittent Claudication to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Intermittent Claudication Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Intermittent Claudication Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Intermittent Claudication to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Intermittent Claudication Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Intermittent Claudication Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Intermittent Claudication Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Intermittent Claudication Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Intermittent Claudication Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Intermittent Claudication Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Intermittent Claudication Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Intermittent Claudication Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Intermittent Claudication Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Intermittent Claudication Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Intermittent Claudication Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Intermittent Claudication Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Intermittent Claudication Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 32
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytokinetics, Inc., 2014* 33
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by Nissan Chemical Industries, Ltd., 2014* 34
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2014* 35
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by ZonMw, 2014* 36
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim Auslandsbeteiligungs GmbH, 2014* 37
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 38
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by Adamed Sp. z o.o., 2014* 39
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014* 40
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by Angiogenix, Inc., 2014* 41
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Aging, 2014* 42
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Angers, 2014* 43
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Hull, 2014* 44
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2014* 45
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by Copenhagen University Hospital at Herlev, 2014* 46
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 47
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2014* 48
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014* 49
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014* 50
Intermittent Claudication Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheffield Teaching Hospitals NHS Foundation Trust, 2014* 51

List of Figures
Intermittent Claudication Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Intermittent Claudication Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Intermittent Claudication Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Intermittent Claudication Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Intermittent Claudication Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Intermittent Claudication Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Intermittent Claudication Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Intermittent Claudication Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Intermittent Claudication to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Intermittent Claudication Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Intermittent Claudication Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Intermittent Claudication to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Intermittent Claudication Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Intermittent Claudication Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Intermittent Claudication Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Intermittent Claudication Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Intermittent Claudication Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Intermittent Claudication Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Intermittent Claudication Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Intermittent Claudication Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Intermittent Claudication Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Intermittent Claudication Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Intermittent Claudication Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 70

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[間欠性跛行(Intermittent Claudication):治療薬のグローバル治験動向(2014年下半期)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆